Recount of FOURIER Data Finds Higher Mortality With Evolocumab Recount of FOURIER Data Finds Higher Mortality With Evolocumab

A readjudication of mortality data from the FOURIER trial by outside researchers concludes CV death was higher with evolocumab than originally reported. But FOURIER trialists stand by their conclusions.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Cardiology | Heart